Abstract
Ten pediatric medulloblastoma patients were analyzed for DNA content, cell cycle, expression of drug resistance, apoptosis, cell proliferation, andN-myc genes to determine their prognostic significance. Medulloblastoma patients with progressive disease had fourth ventricle foraminal extension and larger tumors in the imaging studies. Patients with aneuploid tumors responded well to treatment regimens as compared with those with diploid tumors. Cell cycle analysis showed that the patients with progressive disease had a high S-phase fraction in the tumor cell population as compared with patients with favorable response to treatment. The correlation coefficients betweenBcl-2 andMRP, Bcl-2 andBax, p53 andp21, as well asKi67 andPCNA were positive and significant, indicating their possible coregulated expression. The relationship between these markers indicates their relative and cumulative effect on cellular drug resistance, apoptosis, and/or cell proliferation in pediatric medulloblastomas.
Similar content being viewed by others
References
Friedman HS, Oakes WJ, Bigner SH, et al (1991) Medulloblastoma: tumor biological and clinical perspectives. J Neurooncol 11:1–15
Walker RW, Rosenbum MK (1992) Childhood medulloblastoma. Rev Neurol (Paris) 148:467–476
Provias JP, Becker LE (1996) Cellular and molecular pathology of medulloblastoma. J Neurooncol 29:35–43
Cushing H (1930) Experiences with the cerebellar medulloblastomas: a critical review. Acta Pathol Microbiol Scand 7:1–86
Trojanowski JQ, Fung K-M, Rorke LB, et al (1994) In vivo and in vitro models of medulloblastomas and other primitive neuroectodermal brain tumors of childhood. Mol Chem Neuropathol 21:219–239
Schiffer D, Cavalla P, Chio A, et al (1994) Tumor cell proliferation and apoptosis in medulloblastoma. Acta Neuropathol (Berl) 87:362–370
Jay V, Parkinson D, Becker L, et al (1994) Cell kinetic analysis in pediatric brain and spinal tumors: a study of 117 cases with Ki67 quantitation and flow cytometry. Pediatr Pathol 14:253–276
Chou PM, Reyes-Mugica M, Barquin N, et al (1995) Multidrug resistance gene expression in childhood medulloblastoma: correlation with clinical outcome and DNA ploidy in 29 patients. Pediatr Neurosurg 23:283–292
Rouah E, Wilson DR, Armstrong DL, et al (1989) N-myc amplification and neuronal differentiation in human primitive neuroectodermal tumors of the central nervous system. Cancer Res 49:1797–1801
Bandiali M, Pession A, Basso G, et al (1991) N-myc and C-myc oncogene amplification in medulloblastomas: evidence of particularly aggressive behavior of a tumor with C-myc amplification. Tumori 77:118–121
Tomilson FH, Jenkins RB, Scheithauer BW, et al (1994) Aggressive medulloblastoma with high level N-myc amplification. Mayo Clin Proc 69:359–365
Ramachandran C, Melnick SJ, Escalon E, et al (2000) Expression of apoptosis, cell proliferation and drug resistance in pediatric Wilms' tumors. Anticancer Res 20:3759–3766
Ramachandran C, Melnick SJ, Escalon E, et al (2001) Cytogenetic and molecular characterization of a congenital mesoblastic nephroma. Pediatr Develop Pathol 4:402–411
Ramachandran C, Mead D, Wellham LL, et al (1995) Expression of drug resistance-associated mdr-1, GST π and topoisomerase II genes during cell cycle traverse. Biochem Pharmacol 49:545–552
Ramachandran C, Kunikane H, You W, et al (1998) Phorbol ester-induced P-glycoprotein phosphorylation and functionality in the HTB-123 human breast cancer cell line. Biochem Pharmacol 56:709–718
Gajjar A, Heideman RL, Douglass EC, et al (1993) Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J Clin Oncol 6:1212–1216
Zerbini C, Gelber RD, Weinberg D, et al (1993) Prognostic factors in medulloblastoma, including DNA ploidy. J Clin Oncol 4:616–622
Meyer JS, Marchosky A, Hickey WF (1993) Cell kinetic classification of tumors of the nervous system by DNA precursor labeling in vitro. Hum Pathol 24:1357–1364
Yasue M, Tomita T, Engelhard H, et al (1989) Prognostic importance of DNA ploidy in medulloblastoma of childhood. J Neurosurg 70:385–391
Miyashita T, Reed JC (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151–157
Walton MI, Whyson D, O'Connor PM, et al (1993) Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res 53:1853–1861
Grant CE, Valdimarsson G, Hipfner DR, et al (1994) Over-expression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54:357–361
Loe DW, Deeley RG, Cole SPC (1996) Biology of the Multidrug Resistance-associated Protein. MRP Eur J Cancer 32A:945–957
Nunez G, Clarke MF (1994) The Bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol 4:399–403
Hara A, Hirose Y, Yoshimi N, et al (1997) Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors. Neurol Res 19:623–628
Oltivai ZN, Milliman CL, Korsemeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609–616
Canman CE, Kastan MB (1997) Role of p53 in apoptosis. Adv Pharmacol 41:429–460
El-Deiry WS, Tokino T, Velculescu VE, et al (1993) Wafl, a potential mediator of p53 tumor suppressor. Cell 75:817–825
Gerdes J, Lemke H, Baisch H, et al (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol 133:1710–1715
Scott RJ, Hall PA, Haldane JS, et al (1991) A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 165:173–178
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ramachandran, C., Khatib, Z., Escalon, E. et al. Molecular studies in pediatric medulloblastomas. Brain Tumor Pathol 19, 15–22 (2002). https://doi.org/10.1007/BF02482451
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02482451